深度学习预测胶质瘤异柠檬酸脱氢酶及1p/19q共缺失的MRI诊断效能:系统综述与荟萃分析
Diagnostic performance of deep learning for predicting glioma isocitrate dehydrogenase and 1p/19q co-deletion in MRI: a systematic review and meta-analysis
AI总结:
本文通过系统综述与荟萃分析评估了深度学习影像组学模型基于MRI预测胶质瘤IDH突变和1p/19q共缺失的诊断效能,发现其具有中等准确性,并指出分割方法和DL整合程度是影响异质性的关键因素,临床转化仍需多中心标准化与前瞻性验证。
摘要:
目的:我们旨在评估基于深度学习(DL)的影像组学模型利用MRI序列无创预测胶质瘤患者异柠檬酸脱氢酶(IDH)突变和1p/19q共缺失状态的诊断效能,并识别影响准确性和泛化性的方法学因素。材料与方法:遵循PRISMA指南,我们系统检索了截至2025年3月的主要数据库(PubMed、Scopus、Embase、Web of Science和Google Scholar),筛选利用DL从MRI数据预测IDH和1p/19q共缺失状态的研究。我们使用影像组学质量评分和QUADAS-2工具评估研究质量和偏倚风险。荟萃分析采用双变量模型计算合并敏感性和特异性,并通过荟萃回归评估研究间异质性。结果:在1517篇去重后的文献中,104篇纳入定性综合,72篇进入荟萃分析。测试队列中IDH预测的合并估计值为敏感性0.80、特异性0.85;1p/19q共缺失预测的敏感性为0.75、特异性为0.82。荟萃回归发现肿瘤分割方法和DL在影像组学流程中的整合程度是研究间变异性的显著贡献因素。结论:尽管DL模型在胶质瘤无创分子分型方面展现出强大潜力,临床转化仍需若干关键步骤:采用直方图匹配和基于DL的风格迁移等技术协调多中心MRI数据;采用标准化和自动化的分割方案;开展广泛的多中心外部验证;以及前瞻性临床验证。
英文摘要:
Objectives We aimed to evaluate the diagnostic performance of deep learning (DL)-based radiomics models for the noninvasive prediction of isocitrate dehydrogenase (IDH) mutation and 1p/19q co-deletion status in glioma patients using MRI sequences, and to identify methodological factors influencing accuracy and generalizability. Materials and methods Following PRISMA guidelines, we systematically searched major databases (PubMed, Scopus, Embase, Web of Science, and Google Scholar) up to March 2025, screening studies that utilized DL to predict IDH and 1p/19q co-deletion status from MRI data. We assessed study quality and risk of bias using the Radiomics Quality Score and the QUADAS-2 tool. Our meta-analysis employed a bivariate model to compute pooled sensitivity and specificity, and meta-regression to assess interstudy heterogeneity. Results Among the 1517 unique publications, 104 were included in the qualitative synthesis, and 72 underwent meta-analysis. Pooled estimates for IDH prediction in test cohorts yielded a sensitivity of 0.80 and specificity of 0.85. For 1p/19q co-deletion, sensitivity was 0.75 and specificity was 0.82. Meta-regression identified the tumor segmentation method and the extent of DL integration into the radiomics pipeline as significant contributors to interstudy variability. Conclusion Although DL models demonstrate strong potential for noninvasive molecular classification of gliomas, clinical translation requires several critical steps: harmonization of multi-center MRI data using techniques such as histogram matching and DL-based style transfer; adoption of standardized and automated segmentation protocols; extensive multi-center external validation; and prospective clinical validation.
机构、总结、中文摘要均由AI分析而来,可能存在错误,请以论文正文为准。